465 related articles for article (PubMed ID: 28606059)
1. Observed versus predicted cardiovascular events and all-cause death in HIV infection: a longitudinal cohort study.
De Socio GV; Pucci G; Baldelli F; Schillaci G
BMC Infect Dis; 2017 Jun; 17(1):414. PubMed ID: 28606059
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection.
Triant VA; Perez J; Regan S; Massaro JM; Meigs JB; Grinspoon SK; D'Agostino RB
Circulation; 2018 May; 137(21):2203-2214. PubMed ID: 29444987
[TBL] [Abstract][Full Text] [Related]
3. HIV infection and cardiovascular disease in women.
Womack JA; Chang CC; So-Armah KA; Alcorn C; Baker JV; Brown ST; Budoff M; Butt AA; Gibert C; Goetz MB; Gottdiener J; Gottlieb S; Justice AC; Leaf D; McGinnis K; Rimland D; Rodriguez-Barradas MC; Sico J; Skanderson M; Tindle H; Tracy RP; Warner A; Freiberg MS
J Am Heart Assoc; 2014 Oct; 3(5):e001035. PubMed ID: 25324353
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil to Lymphocyte Ratio and Cardiovascular Disease Incidence in HIV-Infected Patients: A Population-Based Cohort Study.
Quiros-Roldan E; Raffetti E; Donato F; Magoni M; Pezzoli C; Ferraresi A; Brianese N; Castelnuovo F; Focà E; Castelli F
PLoS One; 2016; 11(5):e0154900. PubMed ID: 27148878
[TBL] [Abstract][Full Text] [Related]
5. Traditional Cardiovascular Risk Factors Strongly Underestimate the 5-Year Occurrence of Cardiovascular Morbidity and Mortality in Spinal Cord Injured Individuals.
Barton TJ; Low DA; Bakker EA; Janssen T; de Groot S; van der Woude L; Thijssen DHJ
Arch Phys Med Rehabil; 2021 Jan; 102(1):27-34. PubMed ID: 32861666
[TBL] [Abstract][Full Text] [Related]
6. Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study.
Lichtenstein KA; Armon C; Buchacz K; Chmiel JS; Buckner K; Tedaldi EM; Wood K; Holmberg SD; Brooks JT;
Clin Infect Dis; 2010 Aug; 51(4):435-47. PubMed ID: 20597691
[TBL] [Abstract][Full Text] [Related]
7. The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol.
Durand M; Chartrand-Lefebvre C; Baril JG; Trottier S; Trottier B; Harris M; Walmsley S; Conway B; Wong A; Routy JP; Kovacs C; MacPherson PA; Monteith KM; Mansour S; Thanassoulis G; Abrahamowicz M; Zhu Z; Tsoukas C; Ancuta P; Bernard N; Tremblay CL;
BMC Infect Dis; 2017 Sep; 17(1):611. PubMed ID: 28893184
[TBL] [Abstract][Full Text] [Related]
8. Proximal aortic distensibility is an independent predictor of all-cause mortality and incident CV events: the MESA study.
Redheuil A; Wu CO; Kachenoura N; Ohyama Y; Yan RT; Bertoni AG; Hundley GW; Duprez DA; Jacobs DR; Daniels LB; Darwin C; Sibley C; Bluemke DA; Lima JAC
J Am Coll Cardiol; 2014 Dec; 64(24):2619-2629. PubMed ID: 25524341
[TBL] [Abstract][Full Text] [Related]
9. An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study.
Friis-Møller N; Ryom L; Smith C; Weber R; Reiss P; Dabis F; De Wit S; Monforte AD; Kirk O; Fontas E; Sabin C; Phillips A; Lundgren J; Law M;
Eur J Prev Cardiol; 2016 Jan; 23(2):214-23. PubMed ID: 25882821
[TBL] [Abstract][Full Text] [Related]
10. Global cardiovascular mortality risk in the adult Polish population: prospective assessment of the cohorts studied in multicentre national WOBASZ and WOBASZ Senior studies.
Piotrowski W; Waśkiewicz A; Cicha-Mikołajczyk A
Kardiol Pol; 2016; 74(3):262-73. PubMed ID: 26365939
[TBL] [Abstract][Full Text] [Related]
11. General cardiovascular risk profile for use in primary care: the Framingham Heart Study.
D'Agostino RB; Vasan RS; Pencina MJ; Wolf PA; Cobain M; Massaro JM; Kannel WB
Circulation; 2008 Feb; 117(6):743-53. PubMed ID: 18212285
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular disease risk among Chinese antiretroviral-naïve adults with advanced HIV disease.
Guo F; Hsieh E; Lv W; Han Y; Xie J; Li Y; Song X; Li T
BMC Infect Dis; 2017 Apr; 17(1):287. PubMed ID: 28427339
[TBL] [Abstract][Full Text] [Related]
13. Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.
Van Den Eeden SK; Albers KB; Davidson JE; Kushida CA; Leimpeter AD; Nelson LM; Popat R; Tanner CM; Bibeau K; Quesenberry CP
Sleep; 2015 Jul; 38(7):1009-15. PubMed ID: 26083613
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease-related mortality and factors associated with cardiovascular events in the TREAT Asia HIV Observational Database (TAHOD).
Bijker R; Jiamsakul A; Uy E; Kumarasamy N; Ditango R; Chaiwarith R; Wong WW; Avihingsanon A; Sun LP; Yunihastuti E; Pujari S; Do CD; Merati TP; Kantipong P; Nguyen KV; Kamarulzaman A; Zhang F; Lee MP; Choi JY; Tanuma J; Ng OT; Sim B; Ross J; Kiertiburanakul S;
HIV Med; 2019 Mar; 20(3):183-191. PubMed ID: 30620108
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study.
Davis WA; Colagiuri S; Davis TM
Med J Aust; 2009 Feb; 190(4):180-4. PubMed ID: 19220181
[TBL] [Abstract][Full Text] [Related]
16. Severe infection increases cardiovascular risk among HIV-infected individuals.
Mesquita EC; Coelho LE; Amancio RT; Veloso V; Grinsztejn B; Luz P; Bozza FA
BMC Infect Dis; 2019 Apr; 19(1):319. PubMed ID: 30975092
[TBL] [Abstract][Full Text] [Related]
17. Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
Shah R; Matthews GJ; Shah RY; McLaughlin C; Chen J; Wolman M; Master SR; Chai B; Xie D; Rader DJ; Raj DS; Mehta NN; Budoff M; Fischer MJ; Go AS; Townsend RR; He J; Kusek JW; Feldman HI; Foulkes AS; Reilly MP;
Am J Kidney Dis; 2015 Aug; 66(2):266-73. PubMed ID: 25795074
[TBL] [Abstract][Full Text] [Related]
18. Bilirubin Is Inversely Associated With Cardiovascular Disease Among HIV-Positive and HIV-Negative Individuals in VACS (Veterans Aging Cohort Study).
Marconi VC; Duncan MS; So-Armah K; Re VL; Lim JK; Butt AA; Goetz MB; Rodriguez-Barradas MC; Alcorn CW; Lennox J; Beckman JA; Justice A; Freiberg M
J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29720501
[TBL] [Abstract][Full Text] [Related]
19. The TyG index may predict the development of cardiovascular events.
Sánchez-Íñigo L; Navarro-González D; Fernández-Montero A; Pastrana-Delgado J; Martínez JA
Eur J Clin Invest; 2016 Feb; 46(2):189-97. PubMed ID: 26683265
[TBL] [Abstract][Full Text] [Related]
20. Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals.
Gillis J; Smieja M; Cescon A; Rourke SB; Burchell AN; Cooper C; Raboud JM;
Antivir Ther; 2014; 19(3):309-17. PubMed ID: 24429380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
